摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙氧基-2-氟苯胺盐酸盐 | 380430-46-6

中文名称
4-乙氧基-2-氟苯胺盐酸盐
中文别名
——
英文名称
4-ethoxy-2-fluoroaniline hydrochloride
英文别名
4-ethoxy-2-fluoroaniline;hydrochloride
4-乙氧基-2-氟苯胺盐酸盐化学式
CAS
380430-46-6
化学式
C8H10FNO*ClH
mdl
——
分子量
191.633
InChiKey
DJLOCUSOGLHJOC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    192-195°C

计算性质

  • 辛醇/水分配系数(LogP):
    2.23
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    35.2
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2922299090
  • 储存条件:
    | 室温 |

SDS

SDS:546e62b9b220d1d761810079ac8a0876
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Ethoxy-2-fluoroaniline, HCl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Ethoxy-2-fluoroaniline, HCl
CAS number: 380430-46-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11ClFNO
Molecular weight: 191.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    4-乙氧基-2-氟苯胺盐酸盐C.I.酸性橙108N,N'-硫羰基二咪唑三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 19.17h, 以92%的产率得到N-[4-(ethyloxy)-2-fluorophenyl]-N'-(2-hydroxyethyl)thiourea
    参考文献:
    名称:
    [EN] THIAZOLES WHICH POTENTIATE AMPA RECEPTOR AND MEDICINAL USES THEREOF
    [FR] THIAZOLES QUI POTENTIALISENT LE RÉCEPTEUR AMPA ET UTILISATIONS MÉDICINALES DE CEUX-CI
    摘要:
    该发明提供了式(I)化合物及其盐:其中R1、R2、R3、R4和X的定义如描述中所示。还公开了制备过程、药物组合物以及将其用作药物的用途,例如在治疗由谷氨酸受体功能减弱或失衡介导的疾病或症状,如精神分裂症或认知障碍。
    公开号:
    WO2009053449A1
点击查看最新优质反应信息

文献信息

  • IDO INHIBITORS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20160289171A1
    公开(公告)日:2016-10-06
    There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    已披露的化合物可调节或抑制吲哌酮胺2,3-二氧化酶(IDO)的酶活性,含有该化合物的药物组合物以及利用本发明的化合物治疗增殖性疾病,如癌症、病毒感染和/或炎症性疾病的方法。
  • [EN] THIAZOLES WHICH POTENTIATE AMPA RECEPTOR AND MEDICINAL USES THEREOF<br/>[FR] THIAZOLES QUI POTENTIALISENT LE RÉCEPTEUR AMPA ET UTILISATIONS MÉDICINALES DE CEUX-CI
    申请人:GLAXO GROUP LTD
    公开号:WO2009053449A1
    公开(公告)日:2009-04-30
    The invention provides compounds of formula (I) and salts thereof: wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
    该发明提供了式(I)化合物及其盐:其中R1、R2、R3、R4和X的定义如描述中所示。还公开了制备过程、药物组合物以及将其用作药物的用途,例如在治疗由谷氨酸受体功能减弱或失衡介导的疾病或症状,如精神分裂症或认知障碍。
查看更多